• +1-646-491-9876
    • +91-20-67278686

    Search

    Global Solid Tumors Drugs Market Research Report 2016

    Global Solid Tumors Drugs Market Research Report 2016

    • Report Code ID: RW0001381037
    • Category Pharmaceuticals
    • No. of Pages 114
    • Publication Month Sep-16
    • Publisher Name QY Research
    Notes:
    Production, means the output of Solid Tumors Drugs
    Revenue, means the sales value of Solid Tumors Drugs

    This report studies Solid Tumors Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering
    Hoffmann-La Roche
    Novartis
    Celgene
    Johnson & Johnson
    Pfizer
    BMS
    AbbVie
    AbGenomics
    ADC Therapeutics
    TG Therapeutics
    Polaris Pharmaceuticals
    Immunogen
    CTI BioPharma
    Chugai Pharmaceutical
    NewLink Genetics
    Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Solid Tumors Drugs in these regions, from 2011 to 2021 (forecast), like
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
    Type I
    Type II
    Type III
    Split by application, this report focuses on consumption, market share and growth rate of Solid Tumors Drugs in each application, can be divided into
    Application 1
    Application 2
    Application 3
    Table of Contents

    Global Solid Tumors Drugs Market Research Report 2016
    1 Solid Tumors Drugs Market Overview
    1.1 Product Overview and Scope of Solid Tumors Drugs
    1.2 Solid Tumors Drugs Segment by Type
    1.2.1 Global Production Market Share of Solid Tumors Drugs by Type in 2015
    1.2.2 Type I
    1.2.3 Type II
    1.2.4 Type III
    1.3 Solid Tumors Drugs Segment by Application
    1.3.1 Solid Tumors Drugs Consumption Market Share by Application in 2015
    1.3.2 Application 1
    1.3.3 Application 2
    1.3.4 Application 3
    1.4 Solid Tumors Drugs Market by Region
    1.4.1 North America Status and Prospect (2011-2021)
    1.4.2 Europe Status and Prospect (2011-2021)
    1.4.3 China Status and Prospect (2011-2021)
    1.4.4 Japan Status and Prospect (2011-2021)
    1.4.5 Southeast Asia Status and Prospect (2011-2021)
    1.4.6 India Status and Prospect (2011-2021)
    1.5 Global Market Size (Value) of Solid Tumors Drugs (2011-2021)

    2 Global Solid Tumors Drugs Market Competition by Manufacturers
    2.1 Global Solid Tumors Drugs Production and Share by Manufacturers (2015 and 2016)
    2.2 Global Solid Tumors Drugs Revenue and Share by Manufacturers (2015 and 2016)
    2.3 Global Solid Tumors Drugs Average Price by Manufacturers (2015 and 2016)
    2.4 Manufacturers Solid Tumors Drugs Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Solid Tumors Drugs Market Competitive Situation and Trends
    2.5.1 Solid Tumors Drugs Market Concentration Rate
    2.5.2 Solid Tumors Drugs Market Share of Top 3 and Top 5 Manufacturers
    2.5.3 Mergers & Acquisitions, Expansion

    3 Global Solid Tumors Drugs Production, Revenue (Value) by Region (2011-2016)
    3.1 Global Solid Tumors Drugs Production and Market Share by Region (2011-2016)
    3.2 Global Solid Tumors Drugs Revenue (Value) and Market Share by Region (2011-2016)
    3.3 Global Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
    3.4 North America Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
    3.5 Europe Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
    3.6 China Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
    3.7 Japan Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
    3.8 Southeast Asia Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
    3.9 India Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)

    4 Global Solid Tumors Drugs Supply (Production), Consumption, Export, Import by Regions (2011-2016)
    4.1 Global Solid Tumors Drugs Consumption by Regions (2011-2016)
    4.2 North America Solid Tumors Drugs Production, Consumption, Export, Import by Regions (2011-2016)
    4.3 Europe Solid Tumors Drugs Production, Consumption, Export, Import by Regions (2011-2016)
    4.4 China Solid Tumors Drugs Production, Consumption, Export, Import by Regions (2011-2016)
    4.5 Japan Solid Tumors Drugs Production, Consumption, Export, Import by Regions (2011-2016)
    4.6 Southeast Asia Solid Tumors Drugs Production, Consumption, Export, Import by Regions (2011-2016)
    4.7 India Solid Tumors Drugs Production, Consumption, Export, Import by Regions (2011-2016)

    5 Global Solid Tumors Drugs Production, Revenue (Value), Price Trend by Type
    5.1 Global Solid Tumors Drugs Production and Market Share by Type (2011-2016)
    5.2 Global Solid Tumors Drugs Revenue and Market Share by Type (2011-2016)
    5.3 Global Solid Tumors Drugs Price by Type (2011-2016)
    5.4 Global Solid Tumors Drugs Production Growth by Type (2011-2016)

    6 Global Solid Tumors Drugs Market Analysis by Application
    6.1 Global Solid Tumors Drugs Consumption and Market Share by Application (2011-2016)
    6.2 Global Solid Tumors Drugs Consumption Growth Rate by Application (2011-2016)
    6.3 Market Drivers and Opportunities
    6.3.1 Potential Applications
    6.3.2 Emerging Markets/Countries

    7 Global Solid Tumors Drugs Manufacturers Profiles/Analysis
    7.1 Hoffmann-La Roche
    7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
    7.1.2 Solid Tumors Drugs Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
    7.1.3 Hoffmann-La Roche Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
    7.1.4 Main Business/Business Overview
    7.2 Novartis
    7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
    7.2.2 Solid Tumors Drugs Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
    7.2.3 Novartis Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
    7.2.4 Main Business/Business Overview
    7.3 Celgene
    7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
    7.3.2 Solid Tumors Drugs Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
    7.3.3 Celgene Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
    7.3.4 Main Business/Business Overview
    7.4 Johnson & Johnson
    7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
    7.4.2 Solid Tumors Drugs Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
    7.4.3 Johnson & Johnson Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
    7.4.4 Main Business/Business Overview
    7.5 Pfizer
    7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
    7.5.2 Solid Tumors Drugs Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
    7.5.3 Pfizer Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
    7.5.4 Main Business/Business Overview
    7.6 BMS
    7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
    7.6.2 Solid Tumors Drugs Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
    7.6.3 BMS Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
    7.6.4 Main Business/Business Overview
    7.7 AbbVie
    7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
    7.7.2 Solid Tumors Drugs Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
    7.7.3 AbbVie Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
    7.7.4 Main Business/Business Overview
    7.8 AbGenomics
    7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
    7.8.2 Solid Tumors Drugs Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
    7.8.3 AbGenomics Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
    7.8.4 Main Business/Business Overview
    7.9 ADC Therapeutics
    7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
    7.9.2 Solid Tumors Drugs Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
    7.9.3 ADC Therapeutics Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
    7.9.4 Main Business/Business Overview
    7.10 TG Therapeutics
    7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
    7.10.2 Solid Tumors Drugs Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
    7.10.3 TG Therapeutics Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
    7.10.4 Main Business/Business Overview
    7.11 Polaris Pharmaceuticals
    7.12 Immunogen
    7.13 CTI BioPharma
    7.14 Chugai Pharmaceutical
    7.15 NewLink Genetics

    8 Solid Tumors Drugs Manufacturing Cost Analysis
    8.1 Solid Tumors Drugs Key Raw Materials Analysis
    8.1.1 Key Raw Materials
    8.1.2 Price Trend of Key Raw Materials
    8.1.3 Key Suppliers of Raw Materials
    8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
    8.2.1 Raw Materials
    8.2.2 Labor Cost
    8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Solid Tumors Drugs

    9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Solid Tumors Drugs Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Solid Tumors Drugs Major Manufacturers in 2015
    9.4 Downstream Buyers

    10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
    10.1.1 Direct Marketing
    10.1.2 Indirect Marketing
    10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
    10.2.1 Pricing Strategy
    10.2.2 Brand Strategy
    10.2.3 Target Client
    10.3 Distributors/Traders List

    11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
    11.1.1 Substitutes Threat
    11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

    12 Global Solid Tumors Drugs Market Forecast (2016-2021)
    12.1 Global Solid Tumors Drugs Production, Revenue Forecast (2016-2021)
    12.2 Global Solid Tumors Drugs Production, Consumption Forecast by Regions (2016-2021)
    12.3 Global Solid Tumors Drugs Production Forecast by Type (2016-2021)
    12.4 Global Solid Tumors Drugs Consumption Forecast by Application (2016-2021)
    12.5 Solid Tumors Drugs Price Forecast (2016-2021)

    13 Research Findings and Conclusion

    14 Appendix
    Author List
    Disclosure Section
    Research Methodology
    Data Source
    China Disclaimer




    List of Tables and Figures

    Figure Picture of Solid Tumors Drugs
    Figure Global Production Market Share of Solid Tumors Drugs by Type in 2015
    Figure Product Picture of Type I
    Table Major Manufacturers of Type I
    Figure Product Picture of Type II
    Table Major Manufacturers of Type II
    Figure Product Picture of Type III
    Table Major Manufacturers of Type III
    Table Solid Tumors Drugs Consumption Market Share by Application in 2015
    Figure Application 1 Examples
    Figure Application 2 Examples
    Figure Application 3 Examples
    Figure North America Solid Tumors Drugs Revenue (Million USD) and Growth Rate (2011-2021)
    Figure Europe Solid Tumors Drugs Revenue (Million USD) and Growth Rate (2011-2021)
    Figure China Solid Tumors Drugs Revenue (Million USD) and Growth Rate (2011-2021)
    Figure Japan Solid Tumors Drugs Revenue (Million USD) and Growth Rate (2011-2021)
    Figure Southeast Asia Solid Tumors Drugs Revenue (Million USD) and Growth Rate (2011-2021)
    Figure India Solid Tumors Drugs Revenue (Million USD) and Growth Rate (2011-2021)
    Figure Global Solid Tumors Drugs Revenue (Million UDS) and Growth Rate (2011-2021)
    Table Global Solid Tumors Drugs Production of Key Manufacturers (2015 and 2016)
    Table Global Solid Tumors Drugs Production Share by Manufacturers (2015 and 2016)
    Figure 2015 Solid Tumors Drugs Production Share by Manufacturers
    Figure 2016 Solid Tumors Drugs Production Share by Manufacturers
    Table Global Solid Tumors Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
    Table Global Solid Tumors Drugs Revenue Share by Manufacturers (2015 and 2016)
    Table 2015 Global Solid Tumors Drugs Revenue Share by Manufacturers
    Table 2016 Global Solid Tumors Drugs Revenue Share by Manufacturers
    Table Global Market Solid Tumors Drugs Average Price of Key Manufacturers (2015 and 2016)
    Figure Global Market Solid Tumors Drugs Average Price of Key Manufacturers in 2015
    Table Manufacturers Solid Tumors Drugs Manufacturing Base Distribution and Sales Area
    Table Manufacturers Solid Tumors Drugs Product Type
    Figure Solid Tumors Drugs Market Share of Top 3 Manufacturers
    Figure Solid Tumors Drugs Market Share of Top 5 Manufacturers
    Table Global Solid Tumors Drugs Production by Regions (2011-2016)
    Figure Global Solid Tumors Drugs Production and Market Share by Regions (2011-2016)
    Figure Global Solid Tumors Drugs Production Market Share by Regions (2011-2016)
    Figure 2015 Global Solid Tumors Drugs Production Market Share by Regions
    Table Global Solid Tumors Drugs Revenue by Regions (2011-2016)
    Table Global Solid Tumors Drugs Revenue Market Share by Regions (2011-2016)
    Table 2015 Global Solid Tumors Drugs Revenue Market Share by Regions
    Table Global Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
    Table North America Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
    Table Europe Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
    Table China Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
    Table Japan Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
    Table Southeast Asia Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
    Table India Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
    Table Global Solid Tumors Drugs Consumption Market by Regions (2011-2016)
    Table Global Solid Tumors Drugs Consumption Market Share by Regions (2011-2016)
    Figure Global Solid Tumors Drugs Consumption Market Share by Regions (2011-2016)
    Figure 2015 Global Solid Tumors Drugs Consumption Market Share by Regions
    Table North America Solid Tumors Drugs Production, Consumption, Import & Export (2011-2016)
    Table Europe Solid Tumors Drugs Production, Consumption, Import & Export (2011-2016)
    Table China Solid Tumors Drugs Production, Consumption, Import & Export (2011-2016)
    Table Japan Solid Tumors Drugs Production, Consumption, Import & Export (2011-2016)
    Table Southeast Asia Solid Tumors Drugs Production, Consumption, Import & Export (2011-2016)
    Table India Solid Tumors Drugs Production, Consumption, Import & Export (2011-2016)
    Table Global Solid Tumors Drugs Production by Type (2011-2016)
    Table Global Solid Tumors Drugs Production Share by Type (2011-2016)
    Figure Production Market Share of Solid Tumors Drugs by Type (2011-2016)
    Figure 2015 Production Market Share of Solid Tumors Drugs by Type
    Table Global Solid Tumors Drugs Revenue by Type (2011-2016)
    Table Global Solid Tumors Drugs Revenue Share by Type (2011-2016)
    Figure Production Revenue Share of Solid Tumors Drugs by Type (2011-2016)
    Figure 2015 Revenue Market Share of Solid Tumors Drugs by Type
    Table Global Solid Tumors Drugs Price by Type (2011-2016)
    Figure Global Solid Tumors Drugs Production Growth by Type (2011-2016)
    Table Global Solid Tumors Drugs Consumption by Application (2011-2016)
    Table Global Solid Tumors Drugs Consumption Market Share by Application (2011-2016)
    Figure Global Solid Tumors Drugs Consumption Market Share by Application in 2015
    Table Global Solid Tumors Drugs Consumption Growth Rate by Application (2011-2016)
    Figure Global Solid Tumors Drugs Consumption Growth Rate by Application (2011-2016)
    Table Hoffmann-La Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Hoffmann-La Roche Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
    Figure Hoffmann-La Roche Solid Tumors Drugs Market Share (2011-2016)
    Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Novartis Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
    Figure Novartis Solid Tumors Drugs Market Share (2011-2016)
    Table Celgene Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Celgene Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
    Figure Celgene Solid Tumors Drugs Market Share (2011-2016)
    Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Johnson & Johnson Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
    Figure Johnson & Johnson Solid Tumors Drugs Market Share (2011-2016)
    Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Pfizer Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
    Figure Pfizer Solid Tumors Drugs Market Share (2011-2016)
    Table BMS Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table BMS Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
    Figure BMS Solid Tumors Drugs Market Share (2011-2016)
    Table AbbVie Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table AbbVie Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
    Figure AbbVie Solid Tumors Drugs Market Share (2011-2016)
    Table AbGenomics Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table AbGenomics Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
    Figure AbGenomics Solid Tumors Drugs Market Share (2011-2016)
    Table ADC Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table ADC Therapeutics Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
    Figure ADC Therapeutics Solid Tumors Drugs Market Share (2011-2016)
    Table TG Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table TG Therapeutics Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2011-2016)
    Figure TG Therapeutics Solid Tumors Drugs Market Share (2011-2016)
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Solid Tumors Drugs
    Figure Manufacturing Process Analysis of Solid Tumors Drugs
    Figure Solid Tumors Drugs Industrial Chain Analysis
    Table Raw Materials Sources of Solid Tumors Drugs Major Manufacturers in 2015
    Table Major Buyers of Solid Tumors Drugs
    Table Distributors/Traders List
    Figure Global Solid Tumors Drugs Production and Growth Rate Forecast (2016-2021)
    Figure Global Solid Tumors Drugs Revenue and Growth Rate Forecast (2016-2021)
    Table Global Solid Tumors Drugs Production Forecast by Regions (2016-2021)
    Table Global Solid Tumors Drugs Consumption Forecast by Regions (2016-2021)
    Table Global Solid Tumors Drugs Production Forecast by Type (2016-2021)
    Table Global Solid Tumors Drugs Consumption Forecast by Application (2016-2021)

    Request for Sample

    Report Url http://www.reportsweb.com//global-solid-tumors-drugs-market-research-report-2016&type=sample
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire before Buying

    Report Url http://www.reportsweb.com//global-solid-tumors-drugs-market-research-report-2016&type=buying
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire for Discount

    Report Url http://www.reportsweb.com//global-solid-tumors-drugs-market-research-report-2016&type=discount
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments